Presented at Child & Adolescent Psychopharmacology 2010 course in Boston on March 12-14, 2010.

Autism Spectrum Disorder

Education

Overview: Limitations of Current Treatment of Depression Maurizio Fava, MD

Assessing and Managing Metabolic Risk in Bipolar Disorder and Schizophrenia Dost Ongur, MD, PhD

Long-Acting Injectable (LAI) Antipsychotics in Bipolar Disorder and Schizophrenia Oliver Freudenreich, MD, FAPM

Assessment and Treatment of Affective Symptoms in Schizophrenia Oliver Freudenreich, MD, FAPM

Optimal Treatment of Psychosis in Bipolar Disorder Sharmin Ghaznavi, MD, PhD